Pregnancy outcomes and vaccine effectiveness during the period of omicron as the variant of concern, INTERCOVID-2022: a multinational, observational study

Villar J., Conti CPS., Gunier R., Ariff S., Craik R., Cavoretto P., Rauch S., Gandino S., Nieto R., Winsey F., Menis C., Rodriguez G., Savasi V., Tug N., Deantoni S., Fabre M., de Tejada BM., Rodriguez-Sibaja M., Livio S., Napolitano R., Maiz N., Sobrero H., Peterson A., Deruelle P., Giudice C., Teji J., Casale R., Salomon L., Prefumo F., Ismail LC., Gravett M., Vale M., Hernández V., Sentilhes L., Easter S., Capelli C., Marler E., Cáceres D., Crespo GA., Ernawati E., Lipschuetz M., Takahashi K., Vecchiarelli C., Hubka T., Ikenoue S., Tavchioska G., Bako B., Ayede A., Eskenazi B., Thornton J.

In 2021, COVID-19 during pregnancy was reported to be associated with an increased risk of maternal and neonatal outcomes. The SARS-CoV-2 virus has undergone genetic mutations since then and the subsequent impact of the omicron variant on maternal and neonatal health wasunknown. This study aimed to analyze the effects on maternal and perinatal outcomes of omicron during pregnancy as well as vaccine efficacy.

DOI

10.1097/01.aoa.0000990448.90630.09

Type

Journal article

Publisher

Lippincott, Williams & Wilkins

Publication Date

2023-11-20T00:00:00+00:00

Volume

43

Pages

199 - 200

Total pages

1

Keywords

maternal morbidity and mortality, emerging infectious diseases, prevention, low birth weight and health of the newborn, biotechnology, vaccine related, preterm, reproductive health and childbirth, immunization, genetics, maternal health, infectious diseases, pediatric, coronaviruses, conditions affecting the embryonic and fetal periods, perinatal period - conditions originating in perinatal period, pregnancy, women's health

Permalink More information Close